Letters in Drug Design & Discovery

Papers
(The H4-Index of Letters in Drug Design & Discovery is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Repurposing Novel Antagonists for Targeting p7 Viroporin of HCV Using In Silico Approach201
Ligand-based Pharmacophore Modeling, Molecular Docking and Simulation Studies for the Exploration of Natural Potent Antiangiogenic Inhibitors Targeting Heat Shock Protein 9092
Innovative approaches in insulin delivery: Exploring molecular techniques and system developments45
Synthesis and Anticancer Activity of Oral Pt(IV) Prodrugs Containing α-furancarboxylate as an Axial Ligand43
Regulation of Exosomes-Mediated circNR4A1 on Chemoresistance and Biological Effects of Oral Squamous Cell Carcinoma Cells35
Design, Synthesis and In Vitro Anticancer Activity of Benzo[c]chromen-6- one-linked 1,2,3-Triazole35
Recent Developments, Challenges and Opportunities in Targeting the KRAS Pathway29
Synthesis, Molecular Docking Studies, and In vitro Anticancer Evaluation of Novel Tolfenamic Acid Derivatives28
Synthesis, Characterization, and Evaluation of Sulfonium Lipids as Potential Nonviral Gene Vectors26
Plant Secondary Metabolites as Apoptosis-inducing Agents26
Computational Insights on Migraine and Anxiety in Association with BDNF25
Screening and Structure-Activity Relationship of Potential Compounds against Proposed Targets of COVID-19 Infection20
Positive Expression of Paired Box 5 (Pax5) was Associated with Age, Tumor Location, and Tumor Size of Patients with Gastrointestinal Neuroendocrine Tumors (NETs)19
Computational Study of Lactucine and its Derivatives to Investigate its Anti-cancerous Properties Targeting Apoptosis-inducing Protein18
From prediction to design: A machine learning model for de novo bioactive compounds and personalized biotherapeutics18
Mechanistic Investigation of Glycyrrhiza uralensis Effects against Respiratory Ailments: Application of Network Pharmacology and Molecular Docking Approaches18
From stem cells to therapeutics: Advancing islet function restoration through mesenchymal stem cell-based drug research16
An in-silico design of a novel ursodeoxycholic acid analogue for helminthiasis therapy16
Molecular docking, DFT calculations, and molecular dynamics simulations in the computational investigation of hydrazone derivative potential as a COVID-19 receptor inhibitor16
0.18326997756958